$EMMA
Emmaus Life Sciences, Inc.

2022 Q1 Form 10-Q Financial Statement

#000156459022019955 Filed on May 13, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $3.234M $5.335M
YoY Change -39.38% -23.28%
Cost Of Revenue $1.007M $436.0K
YoY Change 130.96% -8.79%
Gross Profit $2.227M $4.899M
YoY Change -54.54% -24.35%
Gross Profit Margin 68.86% 91.83%
Selling, General & Admin $4.829M $4.705M
YoY Change 2.64% -0.42%
% of Gross Profit 216.84% 96.04%
Research & Development $466.0K $1.809M
YoY Change -74.24% 193.19%
% of Gross Profit 20.93% 36.93%
Depreciation & Amortization $11.00K $15.00K
YoY Change -26.67% 0.0%
% of Gross Profit 0.49% 0.31%
Operating Expenses $5.295M $6.514M
YoY Change -18.71% 21.94%
Operating Profit -$3.068M -$1.615M
YoY Change 89.97% -242.42%
Interest Expense $737.0K $1.054M
YoY Change -30.08% -41.44%
% of Operating Profit
Other Income/Expense, Net $222.0K $190.0K
YoY Change 16.84% 533.33%
Pretax Income -$1.645M -$8.404M
YoY Change -80.43% -245.02%
Income Tax -$103.0K $18.00K
% Of Pretax Income
Net Earnings -$1.542M -$8.422M
YoY Change -81.69% -252.88%
Net Earnings / Revenue -47.68% -157.86%
Basic Earnings Per Share -$0.03
Diluted Earnings Per Share -$31.27K -$171.6K
COMMON SHARES
Basic Shares Outstanding 49.31M 49.07M
Diluted Shares Outstanding 49.31M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $813.0K $3.759M
YoY Change -78.37% -89.84%
Cash & Equivalents $813.0K $3.759M
Short-Term Investments
Other Short-Term Assets $379.0K $237.0K
YoY Change 59.92% -63.48%
Inventory $3.453M $6.740M
Prepaid Expenses $399.0K $397.0K
Receivables $938.0K $2.372M
Other Receivables $0.00 $0.00
Total Short-Term Assets $6.448M $14.14M
YoY Change -54.4% -70.68%
LONG-TERM ASSETS
Property, Plant & Equipment $138.0K $109.0K
YoY Change 26.61% -23.24%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $41.29M $43.73M
YoY Change -5.58% 236.93%
Other Assets $297.0K $293.0K
YoY Change 1.37% 1.03%
Total Long-Term Assets $45.05M $48.08M
YoY Change -6.32% 170.85%
TOTAL ASSETS
Total Short-Term Assets $6.448M $14.14M
Total Long-Term Assets $45.05M $48.08M
Total Assets $51.49M $62.22M
YoY Change -17.24% -5.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.873M $1.399M
YoY Change 105.36% -85.01%
Accrued Expenses $6.085M $4.047M
YoY Change 50.36% 24.64%
Deferred Revenue
YoY Change
Short-Term Debt $7.663M $8.800M
YoY Change -12.92% 1296.83%
Long-Term Debt Due $12.86M $4.616M
YoY Change 178.49% -64.52%
Total Short-Term Liabilities $34.55M $24.41M
YoY Change 41.56% -16.01%
LONG-TERM LIABILITIES
Long-Term Debt $4.650M $12.20M
YoY Change -61.87% 1270.22%
Other Long-Term Liabilities $31.51M $34.47M
YoY Change -8.6% -6.75%
Total Long-Term Liabilities $31.51M $34.47M
YoY Change -8.6% -6.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $34.55M $24.41M
Total Long-Term Liabilities $31.51M $34.47M
Total Liabilities $73.79M $58.88M
YoY Change 25.33% -16.74%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$22.30M -$12.68M
YoY Change
Total Liabilities & Shareholders Equity $51.49M $62.22M
YoY Change -17.24% -5.71%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$1.542M -$8.422M
YoY Change -81.69% -252.88%
Depreciation, Depletion And Amortization $11.00K $15.00K
YoY Change -26.67% 0.0%
Cash From Operating Activities -$4.733M -$4.001M
YoY Change 18.3% -321.29%
INVESTING ACTIVITIES
Capital Expenditures $2.000K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $1.229M -$1.769M
YoY Change -169.47%
Cash From Investing Activities $1.227M -$1.769M
YoY Change -169.36% 58866.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.056M 7.046M
YoY Change -70.82% -618.85%
NET CHANGE
Cash From Operating Activities -4.733M -4.001M
Cash From Investing Activities 1.227M -1.769M
Cash From Financing Activities 2.056M 7.046M
Net Change In Cash -1.466M 1.272M
YoY Change -215.25% 186.49%
FREE CASH FLOW
Cash From Operating Activities -$4.733M -$4.001M
Capital Expenditures $2.000K
Free Cash Flow -$4.735M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
222000
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-754000
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1191000
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1132000
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y4M24D
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 emma Long Term Notes Payable Excluding Convertible Long Term Notes Payable
LongTermNotesPayableExcludingConvertibleLongTermNotesPayable
1500000
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
3150000
CY2021Q4 us-gaap Liabilities
Liabilities
78184000
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49311864
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49311864
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
49000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
220022000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-255000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-241266000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-21450000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
56734000
CY2022Q1 us-gaap Gross Profit
GrossProfit
2227000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
466000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1809000
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1460000
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1283000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3369000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3422000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
5295000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
6514000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3068000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1615000
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1172000
CY2022Q1 emma Gain Loss On Warrant Derivative Liabilities
GainLossOnWarrantDerivativeLiabilities
748000
CY2021Q1 emma Gain Loss On Warrant Derivative Liabilities
GainLossOnWarrantDerivativeLiabilities
-529000
CY2022Q1 emma Gain Loss On Investment On Convertible Bond
GainLossOnInvestmentOnConvertibleBond
-133000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-566000
CY2022Q1 emma Gain Loss On Conversion Feature Derivative Note Payable
GainLossOnConversionFeatureDerivativeNotePayable
3080000
CY2021Q1 emma Gain Loss On Conversion Feature Derivative Note Payable
GainLossOnConversionFeatureDerivativeNotePayable
-2338000
CY2021Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
190000
CY2022Q1 us-gaap Interest Expense
InterestExpense
737000
CY2021Q1 us-gaap Interest Expense
InterestExpense
1054000
CY2022Q1 emma Nonoperating Income Expense Including Income Loss From Equity Method Investments
NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments
1423000
CY2021Q1 emma Nonoperating Income Expense Including Income Loss From Equity Method Investments
NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments
-6789000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1645000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8404000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-103000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1542000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-8422000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
350000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
58000
CY2022Q1 emma Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss
OtherComprehensiveIncomeLossReclassificationAdjustmentForLossIncludedInNetIncomeLoss
7000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
350000
CY2022Q1 emma Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss
OtherComprehensiveIncomeLossReclassificationAdjustmentForLossIncludedInNetIncomeLoss
7000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
331000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1542000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-5158000
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
500000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
181000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
58000
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
165000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-8422000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15000
CY2022Q1 emma Inventory Reserve
InventoryReserve
-794000
CY2021Q1 emma Inventory Reserve
InventoryReserve
-162000
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
411000
CY2021Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
669000
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-1205000
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-1180000
CY2022Q1 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
117000
CY2021Q1 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
19000
CY2022Q1 us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
-133000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-566000
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1172000
CY2021Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
1000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
181000
CY2021Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
500000
CY2022Q1 emma Gain Loss On Warrant Derivative Liabilities
GainLossOnWarrantDerivativeLiabilities
748000
CY2021Q1 emma Gain Loss On Warrant Derivative Liabilities
GainLossOnWarrantDerivativeLiabilities
-529000
CY2022Q1 emma Gain Loss On Conversion Feature Derivative Note Payable
GainLossOnConversionFeatureDerivativeNotePayable
3080000
CY2021Q1 emma Gain Loss On Conversion Feature Derivative Note Payable
GainLossOnConversionFeatureDerivativeNotePayable
-2338000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-102000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2176000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-143000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-180000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-103000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-158000
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-160000
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-122000
CY2022Q1 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
10000
CY2021Q1 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
33000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
530000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1295000
CY2021Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
42000
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-123000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4001000
CY2022Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
2919000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2000
CY2022Q1 emma Loan To Equity Method Investee
LoanToEquityMethodInvestee
-1690000
CY2021Q1 emma Loan To Equity Method Investee
LoanToEquityMethodInvestee
-1769000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1227000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1769000
CY2022Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2056000
CY2021Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
700000
CY2021Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
14390000
CY2021Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
844000
CY2021Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
7200000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2056000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7046000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-16000
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-4000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1466000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1272000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
813000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3759000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
212000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
319000
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
4000
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
5000
CY2021Q1 emma Debt Discount Due To Conversion Of Features Derivative
DebtDiscountDueToConversionOfFeaturesDerivative
5555000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1500000
CY2022Q1 emma Working Capital Deficit
WorkingCapitalDeficit
28100000
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
23261199
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
24515738
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3234000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5335000
CY2021Q4 emma Revenue Allowance And Accrual Activities
RevenueAllowanceAndAccrualActivities
5154000
CY2022Q1 emma Revenue Allowance And Accrual Activities Provision Related To Sales In Current Year
RevenueAllowanceAndAccrualActivitiesProvisionRelatedToSalesInCurrentYear
893000
CY2022Q1 emma Revenue Allowance And Accrual Activities Adjustments Related To Prior Period Sales
RevenueAllowanceAndAccrualActivitiesAdjustmentsRelatedToPriorPeriodSales
44000
CY2022Q1 emma Revenue Allowance And Accrual Activities Credit And Payments Made
RevenueAllowanceAndAccrualActivitiesCreditAndPaymentsMade
1549000
CY2022Q1 emma Revenue Allowance And Accrual Activities
RevenueAllowanceAndAccrualActivities
4454000
CY2020Q4 emma Revenue Allowance And Accrual Activities
RevenueAllowanceAndAccrualActivities
2726000
CY2021Q1 emma Revenue Allowance And Accrual Activities Provision Related To Sales In Current Year
RevenueAllowanceAndAccrualActivitiesProvisionRelatedToSalesInCurrentYear
1496000
CY2021Q1 emma Revenue Allowance And Accrual Activities Adjustments Related To Prior Period Sales
RevenueAllowanceAndAccrualActivitiesAdjustmentsRelatedToPriorPeriodSales
21000
CY2021Q1 emma Revenue Allowance And Accrual Activities Credit And Payments Made
RevenueAllowanceAndAccrualActivitiesCreditAndPaymentsMade
1073000
CY2021Q1 emma Revenue Allowance And Accrual Activities
RevenueAllowanceAndAccrualActivities
3128000
CY2022Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1477000
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1439000
CY2022Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
132000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
115000
CY2022Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6028000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6228000
CY2022Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
4184000
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3390000
CY2022Q1 us-gaap Inventory Net
InventoryNet
3453000
CY2021Q4 us-gaap Inventory Net
InventoryNet
4392000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
405000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
394000
CY2020Q3 us-gaap Debt Instrument Call Date Earliest
DebtInstrumentCallDateEarliest
2020-09-28
CY2021 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-126000
CY2020 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-126000
CY2021 us-gaap Other Income
OtherIncome
41000
CY2020 us-gaap Other Income
OtherIncome
41000
CY2022Q1 us-gaap Prepaid Insurance
PrepaidInsurance
466000
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
660000
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
399000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
326000
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
379000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
394000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1244000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1380000
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
543000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
541000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
138000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
147000
CY2022Q1 us-gaap Depreciation
Depreciation
11000
CY2021Q1 us-gaap Depreciation
Depreciation
11000
CY2022Q1 emma Cro Expenses
CROExpenses
699000
CY2021Q4 emma Cro Expenses
CROExpenses
534000
CY2022Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
817000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
477000
CY2022Q1 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
671000
CY2021Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
932000
CY2022Q1 emma Accrued Manufacturing Expenses Current
AccruedManufacturingExpensesCurrent
283000
CY2021Q4 emma Accrued Manufacturing Expenses Current
AccruedManufacturingExpensesCurrent
378000
CY2022Q1 emma Accrued Board Member Compensation
AccruedBoardMemberCompensation
283000
CY2021Q4 emma Accrued Board Member Compensation
AccruedBoardMemberCompensation
136000
CY2022Q1 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
120000
CY2021Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
262000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2873000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2719000
CY2022Q1 emma Interest Payable Related Parties Current
InterestPayableRelatedPartiesCurrent
142000
CY2021Q4 emma Interest Payable Related Parties Current
InterestPayableRelatedPartiesCurrent
91000
CY2022Q1 us-gaap Interest Payable Current
InterestPayableCurrent
618000
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
579000
CY2022Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
877000
CY2021Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1097000
CY2022Q1 emma Accrued Government Rebates And Other Rebates Current
AccruedGovernmentRebatesAndOtherRebatesCurrent
4461000
CY2021Q4 emma Accrued Government Rebates And Other Rebates Current
AccruedGovernmentRebatesAndOtherRebatesCurrent
4371000
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
747000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
332000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6085000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5800000
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
9718000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
9189000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
4650000
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
24262000
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2822000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4404000
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
31507000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
33173000
CY2022Q1 emma Debt Instrument Principal Outstanding Amount
DebtInstrumentPrincipalOutstandingAmount
24262000
CY2022Q1 emma Debt Instrument Principal Outstanding Amount
DebtInstrumentPrincipalOutstandingAmount
24262000
CY2022Q1 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
3921000
CY2022Q1 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
3921000
CY2022Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
20341000
CY2022Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
20341000
CY2022Q1 us-gaap Debt Instrument Convertible Number Of Equity Instruments
DebtInstrumentConvertibleNumberOfEquityInstruments
10126654
CY2022Q1 us-gaap Debt Instrument Convertible Number Of Equity Instruments
DebtInstrumentConvertibleNumberOfEquityInstruments
10126654
CY2021Q4 emma Debt Instrument Principal Outstanding Amount
DebtInstrumentPrincipalOutstandingAmount
22339000
CY2021Q4 emma Debt Instrument Principal Outstanding Amount
DebtInstrumentPrincipalOutstandingAmount
22339000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
4332000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
4332000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
18007000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
18007000
CY2021 us-gaap Debt Instrument Convertible Number Of Equity Instruments
DebtInstrumentConvertibleNumberOfEquityInstruments
10173099
CY2021 us-gaap Debt Instrument Convertible Number Of Equity Instruments
DebtInstrumentConvertibleNumberOfEquityInstruments
10173099
CY2022Q1 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.06
CY2021Q4 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.06
CY2022Q1 emma Debt Weighted Average Effective Interest Rate
DebtWeightedAverageEffectiveInterestRate
0.15
CY2021Q4 emma Debt Weighted Average Effective Interest Rate
DebtWeightedAverageEffectiveInterestRate
0.15
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
19612000
CY2022Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
8236017
CY2022Q1 emma Warrants Exercisable
WarrantsExercisable
6986017
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y1M6D
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-103000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000
CY2022Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
303000
CY2021Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
301000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
880000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1058000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1063000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1092000
CY2022Q1 emma Lessee Operating Leases Liability Payments Due Year Four And Thereafter
LesseeOperatingLeasesLiabilityPaymentsDueYearFourAndThereafter
836000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4929000
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1107000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3822000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3300000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3800000
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.120
CY2022Q1 us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
1200000

Files In Submission

Name View Source Status
0001564590-22-019955-index-headers.html Edgar Link pending
0001564590-22-019955-index.html Edgar Link pending
0001564590-22-019955.txt Edgar Link pending
0001564590-22-019955-xbrl.zip Edgar Link pending
emma-10q_20220331.htm Edgar Link pending
emma-10q_20220331_htm.xml Edgar Link completed
emma-20220331.xsd Edgar Link pending
emma-20220331_cal.xml Edgar Link unprocessable
emma-20220331_def.xml Edgar Link unprocessable
emma-20220331_lab.xml Edgar Link unprocessable
emma-20220331_pre.xml Edgar Link unprocessable
emma-ex101_13.htm Edgar Link pending
emma-ex102_14.htm Edgar Link pending
emma-ex103_15.htm Edgar Link pending
emma-ex311_6.htm Edgar Link pending
emma-ex312_8.htm Edgar Link pending
emma-ex321_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g1eomgg5zlyg000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending